Previous Close | 592.00 |
Open | 592.00 |
Bid | 543.30 |
Ask | 552.00 |
Strike | 380.00 |
Expire Date | 2025-01-17 |
Day's Range | 592.00 - 592.00 |
Contract Range | N/A |
Volume | |
Open Interest | 64 |
Nvidia and the Nasdaq led a big upside market reversal Wednesday. AppLovin led stocks in buy areas. Here's what to do now.
Novo Nordisk stock rose moderately Wednesday after the pharma giant said its new weight-loss drug, amycretin, outperformed Wegovy.
(Bloomberg) -- Roche Holding AG’s shares slid after its closely-watched experimental obesity pill was tied to side effects, including nausea and vomiting, in a small study.Most Read from BloombergHow Americans Voted Their Way Into a Housing CrisisAfter a Record Hot Summer, Pressure Grows for A/C MandatesFor Tenants, AI-Powered Screening Can Be a New Barrier to HousingChicago Halts Hiring as Deficit Tops $1 Billion Through 2025UC Berkeley Gives Transfer Students a Purpose-Built Home on CampusThe